Article info

Download PDFPDF
Original research
Treatment of mild-to-moderate pelvic inflammatory disease with a short-course azithromycin-based regimen versus ofloxacin plus metronidazole: results of a multicentre, randomised controlled trial

Authors

  1. Correspondence to Dr Gillian Dean, Department of Sexual Health & HIV, Brighton and Sussex University Hospitals NHS Trust, Brighton, E Sussex, UK; gillian.dean2{at}nhs.net
View Full Text

Citation

Dean G, Soni S, Pitt R, et al
Treatment of mild-to-moderate pelvic inflammatory disease with a short-course azithromycin-based regimen versus ofloxacin plus metronidazole: results of a multicentre, randomised controlled trial

Publication history

  • Received February 9, 2020
  • Revised September 1, 2020
  • Accepted September 27, 2020
  • First published November 13, 2020.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.